Wednesday, September 1, 2021

Grand Rounds

11:00 AM to 12:00 PM

CME credit available, click here

Virtual event
Zoom ID: 983 3802 4406 Passcode: NeuroGR

"Novel Treatments for Myasthenia Gravis"

Vera Bril, BSc, FRCPC, MD

Professor of Neurology, University Health Network, University of Toronto

Vera Bril, BSc, FRCPC, MD Vera Bril is a Professor of Medicine (Neurology) at the University of Toronto, Director of the Neuromuscular Section, Division of Neurology, University of Toronto and University Health Network. She directs the Ellen & Martin Prossserman Centre for Neuromuscular Diseases at the University Health Network, and the Prosserman Family Neuromuscular Clinic and the Elisabeth Raab Neurofibromatosis Clinic at Toronto General Hospital. She served as the division director of Neurology at University Health Network and Sinai Health System from 2005-2019. She has particular expertise in the diagnosis and management of patients with complex neuromuscular disorders. Her research interests have centered on the diagnosis and evidence-based treatment of myasthenia gravis, inflammatory polyneuropathies, and diabetic sensorimotor polyneuropathy leading to publication of more than 300 journal articles. Her research helped set the standards for electrophysiological investigations in the definition and evaluation of the progression of chronic polyneuropathies and established the role of intravenous immunoglobulin in the treatment of myasthenia gravis, the Guillain-Barré Syndrome and the chronic inflammatory demyelinating polyneuropathy. She has acted as an advisor to Health Canada and the FDA and on numerous scientific advisory boards for industry.